The Vocal
Biomarkers Market Insights and Analysis
by type (frequency, amplitude, error rate, vocal rise or fall time, phonation
time, voice tremor, pitch, others) by indications (psychiatric disorders
(depression, Attention Deficit and Disruptive Behavior Disorders, others),
neurological disorders (Parkinson's disease (PD), Alzheimer's disease,
Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders,
traumatic brain injury (TBI), others), others) by end users (hospitals and
clinics, academic and research, others) - Global Forecast
Global vocal biomarkers market to witness a healthy
growth in forthcoming years projects Market Research Future (MRFR) in its
latest report. Increased prevalence of neurological, psychological and other
disorders that affects speech is fuelling the demand for vocal biomarkers.
Health issues such as Disruptive Behavior Disorders, Alzheimer's disease,
Parkinson's disease (PD), Huntington's disease, attention deficit, depression,
and respiratory and cardiovascular disorders are associated with speech impairment.
There are cases when traumatic brain injury (TBI) was identified as cause of
speech loss. A WHO report revealed that in 2016, close to 350 million people
were suffering from depression. In the same, The Parkinson’s disease Foundation
reported that around 10 million people were suffering Parkinson’s.
Biomarkers are also used for detecting speech
related issues in soldiers. Hence, the defence sector has potential for vocal
biomarker application. For instance, the U.S Army joined forces with MIT
researcher to collaboratively work on developing advanced biomarker technology
that can cater to traumatic brain injury. America Heart Association in
partnership with Mayo Clinic and Beyond Verbal has created unique artificial
intelligence (AI) algorithms using cutting-edge machine-learning tools to
perceive voice patterns uncatchable by human ear for initial identification of
coronary heart disorders.
Rapid mobile technology penetration and boom of the
IT sector is creating supporting the market growth. Moreover, the arrival of
advanced wearable technologies along with improving the network quality and
bandwidth is partly influencing the market. Market players are actively
focusing on product innovation in order to gain a competitive edge. Many
companies are also entering into collaboration and partnerships to boost their
R&D capacity.
Segmental
Overview
The segmental analysis of the global vocal biomarker market share is based on
indication, type and end users.
On the basis of indication, the market has been
segmented into neurological disorders, psychiatric disorders, respiratory
disorders, traumatic brain injury (TBI), cardiovascular disorder. The
neurological disorders segment is further sub-segmented into Alzheimer’s
disease, Parkinson’s disease, huntington’s disease, and others. The psychiatric
disorders segment is further sub-segmented into disruptive behaviour disorders,
attention deficit, depression and others. On the basis of type, the market has
been segmented into pitch, amplitude, vocal rise or fall time, voice tremor,
frequency, error rate, phonation time, and others. On the basis of end users,
the market has been segmented into academic and research, hospitals and clinics
and others.
Global Vocal
Biomarkers Market: Regional Segmentation
The vocal biomarkers market has been covered
across key regions, which include North America, Asia Pacific (APAC), Europe,
the Middle East & Africa (MEA) and Latin America. North America is expected
to remain highly profitable market for vocal biomarkers during the forecast
period. In North America, the U.S. makes a significant contribution to the
vocal biomarker market. This is primarily owing to the presence of effective
reimbursement scenario and high healthcare spending. Moreover, faster
acceptance of the advanced technologies in the U.S. makes it a potential
market. Following on the heels of North America, Europe represents the second
largest market for vocal biomarker. High level of awareness and growing
healthcare expenditure are two of the key factors driving the market in Europe.
Asia-Pacific ranks third in the pecking order in terms revenue. The market in
APAC is touted to witness a strong growth over the next several years. India
and China are major contributors to the market in the region.
Competitive
Landscape
MRFR in its report has mentioned some of leading
companies operating in the global vocal biomarker market, which include Sonde
Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and Audio
Profiling.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New
York 10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment